Q3 2022 Holdings
Filed 2022-10-21 | 465 holdings | $46.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Corvus Pharmaceuticals Inc(CRVS) | Common Stock | 221015100 | $0 | 436 | 0.0% |
| Molecular Templates Inc | Common Stock | 608550109 | $0 | 528 | 0.0% |
| Applied Molecular Transport | Common Stock | 03824M109 | $0 | 364 | 0.0% |
| Applied Therapeutics Inc(APLT) | Common Stock | 03828A101 | $0 | 450 | 0.0% |
| Neoleukin Therapeutics Inc | Common Stock | 64049K104 | $0 | 399 | 0.0% |
| Athenex Inc(ATNXEUR) | Common Stock | 04685N103 | $0 | 1,471 | 0.0% |
| Aeglea Biotherapeutics Inc(AGLEUSD) | Common Stock | 00773J103 | $0 | 573 | 0.0% |
| Obseva SA | Common Stock | H5861P103 | $0 | 792 | 0.0% |
| SAB Biotherapeutics Inc(SABS) | Common Stock | 78397T103 | $0 | 403 | 0.0% |
| Mustang BIO Inc | Common Stock | 62818Q104 | $0 | 986 | 0.0% |
| Avrobio Inc | Common Stock | 05455M100 | $0 | 410 | 0.0% |
| Oncorus Inc | Common Stock | 68236R103 | $0 | 243 | 0.0% |
| Syros Pharmaceuticals Inc(SYRS) | Common Stock | 87184Q206 | $0 | 59 | 0.0% |
| NRX Pharmaceuticals Inc | Common Stock | 629444100 | $0 | 633 | 0.0% |
| Aligos Therapeutics Inc | Common Stock | 01626L105 | $0 | 372 | 0.0% |
| Brooklyn Immunotherapeutics | Common Stock | 114082100 | $0 | 550 | 0.0% |
| Cabaletta BIO Inc(CABA) | Common Stock | 12674W109 | $0 | 272 | 0.0% |
| Sensei Biotherapeutics Inc | Common Stock | 81728A108 | $0 | 288 | 0.0% |
| Landos Biopharma Inc | Common Stock | 515069102 | $0 | 377 | 0.0% |
| Cellectis(CLLS) | ADR | 15117K103 | $0 | 168 | 0.0% |
| Sera Prognostics Inc(SERA) | Common Stock | 81749D107 | $0 | 277 | 0.0% |
| Tonix Pharmaceuticals Holdin | Common Stock | 890260862 | $0 | 419 | 0.0% |
| Quince Therapeutics Inc(QNCX) | Common Stock | 22053A107 | $0 | 338 | 0.0% |
| Solid Biosciences Inc | Common Stock | 83422E105 | $0 | 1,059 | 0.0% |
| Redhill Biopharma LTD | ADR | 757468103 | $0 | 598 | 0.0% |
| Codiak Biosciences Inc(32W) | Common Stock | 192010106 | $0 | 213 | 0.0% |
| Codex DNA Inc | Common Stock | 192003101 | $0 | 277 | 0.0% |
| Rubius Therapeutics Inc | Common Stock | 78116T103 | $0 | 846 | 0.0% |
| Harpoon Therapeutics Inc | Common Stock | 41358P106 | $0 | 310 | 0.0% |
| Rapid Micro Biosystems Inc(RPID) | Common Stock | 75340L104 | $1 | 341 | 0.0% |
| Icosavax Inc | Common Stock | 45114M109 | $1 | 373 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | Common Stock | 481116101 | $1 | 484 | 0.0% |
| Ikena Oncology Inc | Common Stock | 45175G108 | $1 | 340 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | Common Stock | 45665G303 | $1 | 836 | 0.0% |
| Immunic Inc(IMUX) | Common Stock | 4525EP101 | $1 | 287 | 0.0% |
| Impel Pharmaceuticals Inc | Common Stock | 45258K109 | $1 | 223 | 0.0% |
| Werewolf Therapeutics Inc(HOWL) | Common Stock | 95075A107 | $1 | 277 | 0.0% |
| Achilles Therapeutics PL(698) | ADR | 00449L102 | $1 | 366 | 0.0% |
| VOR Biopharma Inc | Common Stock | 929033108 | $1 | 356 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | Common Stock | 00773U108 | $1 | 931 | 0.0% |
| Verrica Pharmaceuticals Inc | Common Stock | 92511W108 | $1 | 385 | 0.0% |
| Verastem Inc | Common Stock | 92337C104 | $1 | 1,759 | 0.0% |
| Akebia Therapeutics Inc(AKBA) | Common Stock | 00972D105 | $1 | 1,721 | 0.0% |
| Tenaya Therapeutics Inc(TNYA) | Common Stock | 87990A106 | $1 | 387 | 0.0% |
| Tcr2 Therapeutics Inc | Common Stock | 87808K106 | $1 | 361 | 0.0% |
| Adaptimmune Therapeutics(ADAPY) | ADR | 00653A107 | $1 | 1,345 | 0.0% |
| Athira Pharma Inc | Common Stock | 04746L104 | $1 | 354 | 0.0% |
| Autolus Therapeutics PLC(AUTL) | ADR | 05280R100 | $1 | 542 | 0.0% |
| Taysha Gene Therapies Inc(TSHA) | Common Stock | 877619106 | $1 | 385 | 0.0% |
| Talaris Therapeutics Inc | Common Stock | 87410C104 | $1 | 391 | 0.0% |